急性虹彩炎的病例治療探討

急性期的前葡萄膜炎(虹彩炎)首要的治療目標是快速將發炎降低，以免造成眼組織的破壞。儘管已經將葡萄膜炎分成許多類型，仍以非感染性占絕大多數；非感染性葡萄膜炎又可依人類白血球組織抗原(human leukocyte antigen，HLA)來分型，但分型對於治療方式也只是居參考作用，眼科仍是以類固醇為主藥治療藥物。對於類固醇治療效果不佳的患者，中藥若使用得當，除可控制發炎外，也可避免進入二線用藥，免除更強藥物所產生的更嚴重副作用。

關鍵字

前葡萄膜炎； HLA ；類固醇

並列摘要

The treatment focus for acute anterior uveitis (AAU), also known as iritis, is to rapidly reduce inflammation and thus avoid destruction of ocular tissue. Though there are many types and subsets of uveitis the noninfectious type remains the most common. Noninfectious uveitis can also be divided into many different subsets with the most common form associated with human leukocyte antigen (HLA). However, the differentiation of these various types is only for reference since corticosteroids remain the primary treatment of ophthalmological pathologies. For patients who do not have effective results with corticosteroids, if administered appropriately traditional Chinese medicine (TCM) can both reduce inflammation and prevent the need to use potent second-line drugs that tend to cause more serious side effects.

並列關鍵字

acute anterior uveitis (AAU) ； iritis ； human leukocyte antigen (HLA) ； corticosteroids

參考文獻

Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop [J], Am J Ophthalmol, 2005, 140(3):509-516